Japan Hits Swiss Pharmaceutical with $33 Million Transfer Pricing Assessment

On March 31, 1993, the tax media reported that the Japanese National Tax Administration has ordered Nippon Roche K.K., a subsidiary of a Swiss drug manufacturer, to pay approximately $33 million in transfer pricing-related back taxes. If it sticks, it would be the highest tax ever imposed on a foreign company. The case illustrates the increasingly high stakes and penalization of international tax cases, especially those concerning transfer pricing…[more]